A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess (0)

by M Stevenson, Jones ML, E De Nigris, N Brewer, S Davis, J Oakley